Development of a SARS Coronavirus Vaccine From Recombinant Spike Protein Plus Delta Inulin Adjuvant
Methods in Molecular Biology - United States
doi 10.1007/978-1-4939-3387-7_14
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2016
Authors
Publisher
Springer New York